9/14/2025 Changes or Headlines for National Healthcare in the past two weeks

Major Policy / Legal / Insurance News

1. CDC losing key experts & cuts at the agency
   There’s concern among public health experts that the departure of senior CDC staff and program budget cuts will diminish the U.S.’s ability to respond to emergent health threats (measles, bird flu, Ebola). Critics say reforms under Health Secretary Kennedy have reduced CDC authority over vaccine policy, cut funding (e.g. for mRNA vaccine research), and weakened overall capability. The Guardian

2. Family doctors urging broader COVID-19 vaccine recommendations
   The American Academy of Family Physicians (AAFP) has recommended that everyone over age 18—including children and pregnant women—receive COVID-19 vaccinations. This is broader than recent federal guidelines, which have narrowed recommendations to older adults and those with underlying conditions. Reuters

3. Court ruling on Planned Parenthood and Medicaid funding
   A U.S. appeals court has ruled that the administration may go ahead with a plan to block Planned Parenthood from receiving Medicaid reimbursements. This could impact access for about 1.1 million Medicaid patients, many in rural or underserved areas. Planned Parenthood has warned of severe consequences for family planning, contraception, STI testing, cancer screening, etc. The Guardian

4. Sharp premium increases expected unless ACA subsidies are extended
   The expanded health insurance subsidies under the Affordable Care Act (ACA), which helped many insured afford premiums (especially middle-income people), are set to expire end of 2025. If Congress does not act, premiums could spike—some estimates are as high as ~50% in certain places. AP News

5. Connecticut insurance premium hikes
   In Connecticut, health insurance premiums for individual plans (on the Access Health CT exchange) are approved to increase ~16.8% on average for 2026; small group plan rates rising around 11%. These increases are tied to anticipated cuts in federal subsidies. CT Insider

6. Medicare home healthcare rate cut delay pushed by bill
   A new bipartisan bill (Home Health Stabilization Act of 2025) has been introduced to stop a proposed ~6.4% cut (about $1.135 billion) to Medicare home health payments for 2026–2027. Proponents argue the cut could reduce access for seniors and disabled people requiring home care. MarketWatch

Medical / Tech / Innovation Updates

1. WIRED Health Summit: Innovations & Biotech Highlights
   At the September 2025 WIRED Health summit, several developments were spotlighted:

   • Progress on CRISPR gene editing for diseases like sickle cell and beta thalassemia.

   • Advances in personalized mRNA cancer vaccines.

   • Use of liquid biopsies to catch cancers earlier.

   • Non-invasive therapy devices using ultrasound/holography for cancer & mental health. WIRED

2. New allergen-blocker antibodies show promise
   Regeneron reported that its first-in-class antibodies blocking cat and birch allergens succeeded in phase 3 trials for adults with moderate-to-severe allergies. HCPLive

3. Withdrawal of a drug for a liver disease
   Intercept Pharmaceuticals voluntarily withdrew obeticholic acid (marketed as Ocaliva) from the U.S. for treating primary biliary cholangitis (PBC). The FDA has also put a hold on related trials. HCPLive

4. Potential first drug for focal segmental glomerulosclerosis (FSGS)
   Travere Therapeutics’ drug sparsentan (Filspari) is under review by the FDA (sNDA). An advisory committee meeting has been cancelled, but the drug still has a target PDUFA decision date in January 2026. If approved, it would be the first indicated drug for FSGS. HCPLive